Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database

database[Title] 2022-07-03

Summary:

CONCLUSIONS: In this historical cohort study within the French nationwide healthcare database, the risk of overall, solid or haematological malignancies did not significantly differ between patients with RA initiating bDMARD and those continuing csDMARDs.

Link:

https://pubmed.ncbi.nlm.nih.gov/35738803/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20220703051906&v=2.17.6

From feeds:

📚BioDBS Bibliography » database[Title]

Tags:

Authors:

Raphaele Seror, Alexandre Lafourcade, Yann De Rycke, Sandrine Pinto, Johann Castaneda, Bruno Fautrel, Xavier Mariette, Florence Tubach

Date tagged:

07/03/2022, 05:19

Date published:

06/23/2022, 06:00